Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1961 1
1963 1
1964 2
1965 1
1967 1
1969 2
1970 2
1971 1
1972 7
1973 3
1974 4
1975 3
1976 4
1977 5
1978 7
1979 2
1980 4
1981 8
1982 4
1983 2
1984 5
1985 1
1986 8
1987 19
1988 9
1989 15
1990 11
1991 16
1992 25
1993 36
1994 30
1995 39
1996 49
1997 58
1998 75
1999 92
2000 100
2001 117
2002 142
2003 206
2004 235
2005 262
2006 275
2007 339
2008 431
2009 458
2010 608
2011 644
2012 735
2013 740
2014 799
2015 815
2016 795
2017 801
2018 783
2019 820
2020 791
2021 838
2022 765
2023 683
2024 640
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12,772 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial.
Bang YJ, Kim YW, Yang HK, Chung HC, Park YK, Lee KH, Lee KW, Kim YH, Noh SI, Cho JY, Mok YJ, Kim YH, Ji J, Yeh TS, Button P, Sirzén F, Noh SH; CLASSIC trial investigators. Bang YJ, et al. Among authors: kim yh. Lancet. 2012 Jan 28;379(9813):315-21. doi: 10.1016/S0140-6736(11)61873-4. Epub 2012 Jan 7. Lancet. 2012. PMID: 22226517 Clinical Trial.
The Efficacy and Safety of SGLT2 Inhibitor in Diabetic Kidney Transplant Recipients.
Lim JH, Kwon S, Jeon Y, Kim YH, Kwon H, Kim YS, Lee H, Kim YL, Kim CD, Park SH, Lee JS, Yoo KD, Son HE, Jeong JC, Lee J, Lee JP, Cho JH. Lim JH, et al. Among authors: kim yh. Transplantation. 2022 Sep 1;106(9):e404-e412. doi: 10.1097/TP.0000000000004228. Epub 2022 Jun 30. Transplantation. 2022. PMID: 35768908
Clinical Practice Guideline for Stroke Rehabilitation in Korea-Part 1: Rehabilitation for Motor Function (2022).
Kim DY, Ryu B, Oh BM, Kim DY, Kim DS, Kim DY, Kim DK, Kim EJ, Lee HY, Choi H, Kim HS, Lee HH, Kim HJ, Oh HM, Seok H, Park J, Park J, Park JG, Kim JM, Lee J, Shin JH, Lee JK, Oh JS, Park KD, Kim KT, Chang MC, Chun MH, Kim MW, Kang MG, Song MK, Choi M, Ko MH, Kim NY, Paik NJ, Jung SH, Yoon SY, Lim SH, Lee SJ, Yoo SD, Lee SH, Yang SN, Park SW, Lee SY, Han SJ, Lee SJ, Bok SK, Ohn SH, Im S, Pyun SB, Hyun SE, Kim SH, Ko SH, Jee S, Kwon S, Kim TW, Chang WH, Chang WK, Yoo WK, Kim YH, Yoo YJ, Kim YW, Shin YI, Park YG, Choi YH, Kim Y; KSNR Stroke CPG Writing Group. Kim DY, et al. Among authors: kim yh. Brain Neurorehabil. 2023 Jul 17;16(2):e18. doi: 10.12786/bn.2023.16.e18. eCollection 2023 Jul. Brain Neurorehabil. 2023. PMID: 37554256 Free PMC article. Review.
PRMT1 promotes pancreatic cancer development and resistance to chemotherapy.
Ku B, Eisenbarth D, Baek S, Jeong TK, Kang JG, Hwang D, Noh MG, Choi C, Choi S, Seol T, Kim H, Kim YH, Woo SM, Kong SY, Lim DS. Ku B, et al. Among authors: kim yh. Cell Rep Med. 2024 Mar 19;5(3):101461. doi: 10.1016/j.xcrm.2024.101461. Epub 2024 Mar 8. Cell Rep Med. 2024. PMID: 38460517 Free PMC article.
Morel-Lavallée Lesion.
Kim YH, Park HY. Kim YH, et al. N Engl J Med. 2021 Dec 2;385(23):2179. doi: 10.1056/NEJMicm2111332. Epub 2021 Nov 27. N Engl J Med. 2021. PMID: 34890502 No abstract available.
4-1BB immunotherapy: advances and hurdles.
Singh R, Kim YH, Lee SJ, Eom HS, Choi BK. Singh R, et al. Among authors: kim yh. Exp Mol Med. 2024 Feb;56(1):32-39. doi: 10.1038/s12276-023-01136-4. Epub 2024 Jan 4. Exp Mol Med. 2024. PMID: 38172595 Free PMC article. Review.
12,772 results
You have reached the last available page of results. Please see the User Guide for more information.